JNJ

227.58

+1.12%↑

UNH

366.5

+3.49%↑

TMO

470.15

+0.34%↑

ISRG

466.67

-0.89%↓

ABT

93.81

+1.03%↑

JNJ

227.58

+1.12%↑

UNH

366.5

+3.49%↑

TMO

470.15

+0.34%↑

ISRG

466.67

-0.89%↓

ABT

93.81

+1.03%↑

JNJ

227.58

+1.12%↑

UNH

366.5

+3.49%↑

TMO

470.15

+0.34%↑

ISRG

466.67

-0.89%↓

ABT

93.81

+1.03%↑

JNJ

227.58

+1.12%↑

UNH

366.5

+3.49%↑

TMO

470.15

+0.34%↑

ISRG

466.67

-0.89%↓

ABT

93.81

+1.03%↑

JNJ

227.58

+1.12%↑

UNH

366.5

+3.49%↑

TMO

470.15

+0.34%↑

ISRG

466.67

-0.89%↓

ABT

93.81

+1.03%↑

Home・Akcijų sąrašas・Microbot Medical Inc

Microbot Medical Inc

Uždarymo kaina

2.1 -3.23

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

2.09

Max

2.17

Pagrindiniai rodikliai
By Trading Economics
Pajamos	113K -3.5M
Darbuotojai	43
EBITDA	-561K -4.1M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+245.62% upside

Dividendai
By Dow Jones
Kitas uždarbis	2026-05-12

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	-24M 146M
Ankstesnė atidarymo kaina	5.33
Ankstesnė uždarymo kaina	2.1

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Neutral Evidence

2.52 / 2.57 Palaikymas ir pasipriešinimas

Microbot Medical Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-04-28 23:33; UTC

Karštos akcijos

Stocks to Watch: Robinhood, Visa, Seagate Technology, NXP Semiconductors

2026-04-28 23:24; UTC

Uždarbis

Visa 2Q Revenue Climbs as Consumers Keep Spending; Board Authorizes $20 Billion Buyback -- Update

2026-04-28 23:15; UTC

Svarbiausios naujienos

U.K. Economy to Suffer Large Loss of Output, Higher Inflation as Result of Middle East Conflict

2026-04-28 22:46; UTC

Uždarbis

Booking Holdings Cuts Outlook as Middle East Conflict Weighs on Travel Demand -- Update

2026-04-28 22:37; UTC

Uždarbis

Prudential PLC 1Q New Business Profit $686.0 Million, Up 10% on Year

2026-04-28 22:15; UTC

Uždarbis

Svarbiausios naujienos

Mondelez Reports Developing Market Growth Offsetting U.S., Europe Weakness -- Update

2026-04-28 23:33; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Gold Edges Lower on Prospects of Dollar Strength -- Market Talk

2026-04-28 23:31; UTC

Uždarbis

China Petroleum & Chemical 1Q Net Rose on Higher Crude Oil Prices >0386.HK

2026-04-28 23:31; UTC

Uždarbis

China Petroleum & Chemical 1Q Capex Was CNY25.17B >0386.HK

2026-04-28 23:30; UTC

Uždarbis

China Petroleum & Chemical 1Q Net CNY17.74B Vs. Net CNY13.98B >0386.HK

2026-04-28 23:30; UTC

Uždarbis

China Petroleum & Chemical 1Q Rev CNY706.70B Vs. CNY735.36B >0386.HK

2026-04-28 23:19; UTC

Rinkos pokalbiai

Uždarbis

Visa Points to Spending Boost from Tax Refunds in U.S. -- Market Talk

2026-04-28 23:09; UTC

Uždarbis

Visa 2Q Revenue Climbs as Consumers Keep Spending; Board Authorizes $20B Buyback -- Update

2026-04-28 23:03; UTC

Rinkos pokalbiai

Australia's Inflation Outlook Looks Pretty Grim -- Market Talk

2026-04-28 23:01; UTC

Svarbiausios naujienos

NIESR Sees One Rate Rise to 4% in Benign Scenario

2026-04-28 23:01; UTC

Svarbiausios naujienos

NIESR Sees U.K. Economy Growing by Just 0.5% in 'Adverse' Middle East Scenario

2026-04-28 23:01; UTC

Svarbiausios naujienos

NIESR: BOE's Key Rate Should Rise to 5.25% in Adverse Scenario

2026-04-28 23:01; UTC

Svarbiausios naujienos

U.K.'s NIESR Lowers 2026 U.K. Economic Growth Forecast to 0.9% From 1.4% in 'Benign' Scenario

2026-04-28 23:01; UTC

Svarbiausios naujienos

NIESR Sees Inflation Peaking at Over 6% in Adverse Scenario

2026-04-28 22:51; UTC

Uždarbis

Robinhood Earnings Fall Short. A Crypto Slump Is the Culprit. -- Barrons.com

2026-04-28 22:48; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-04-28 22:48; UTC

Rinkos pokalbiai

Australia's 1Q CPI Will Likely Provide Little Relief For RBA -- Market Talk

2026-04-28 22:40; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Australian 1Q CPI Will Likely Keep May Hike Alive -- Market Talk

2026-04-28 22:32; UTC

Uždarbis

Booking Beats on Profit. Travel Demand Outlook Clouded By Iran War. -- Barrons.com

2026-04-28 22:25; UTC

Įsigijimai, susijungimai, perėmimai

Pernod Ricard and Brown-Forman End Deal Talks -- Update

2026-04-28 22:22; UTC

Uždarbis

Prudential PLC 1Q New Business Profit $686.0M, Up 10% on Year

2026-04-28 22:17; UTC

Rinkos pokalbiai

Canada Fiscal Update Puts Central Bank on Track to Raise Rates -- Market Talk

2026-04-28 22:14; UTC

Uždarbis

Prudential PLC 1Q APE Sales Up 6% on Year, to $1.823B >2378.HK

2026-04-28 22:14; UTC

Uždarbis

Prudential PLC 1Q New Business Profit $686.0M, Up 10% on Year >2378.HK

2026-04-28 22:07; UTC

Rinkos pokalbiai

Svarbiausios naujienos

Canada Chamber Frets Over Lost Fiscal Room -- Market Talk

Akcijų palyginimas

Kainos pokytis

Microbot Medical Inc Prognozė

Kainos tikslas

By TipRanks

245.62% į viršų

12 mėnesių prognozė

Vidutinis 7.5 USD 245.62%

Aukščiausias 12 USD

Žemiausias 5 USD

Remiantis 3 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Microbot Medical Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

3 ratings

Pirkti

Laikyti

Parduoti

Remiantis 3 analitikų, pateikusių Microbot Medical Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

2.52 / 2.57Palaikymas ir pasipriešinimas

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.